The RADIANCE (Rating Atherosclerosis Disease Change by Imaging with a New Cholesterol-Ester-Transfer Protein Inhibitor) 2 study recruited 752 patients with mixed dyslipidemia.

• 2研究共纳入752名混合型血脂异常的患者。